The Diary Of A CEO with Steven Bartlett

Podbit · The Diary Of A CEO with Steven Bartlett

Most Replayed Moment: Alzheimer's Starts 20 Years Before Symptoms! How To Protect Your Brain Now

Explore episode Aug 7, 2026

Where this was said

The Neuroscience of Heavy Lifting: Myokines, BDNF, and Hippocampal Growth

At 5:05 · chapter starts 5:02

This chapter is the episode's most scientifically rich stretch, and Nicola navigates it with unusual clarity. When you lift at around 80% of your one-rep max, your contracting muscles release a class of molecules called myokines. These aren't passive byproducts — they are active signaling molecules with far-reaching effects. Irisin, one such myokine, crosses the blood-brain barrier and effectively turns on BDNF — brain-derived neurotrophic factor — the brain's primary growth hormone. BDNF then drives the birth of new neurons specifically in the hippocampus, the brain's memory hub and the first region to shrink in Alzheimer's disease. This is why short-term memory is always the first casualty. Another myokine, interleukin-6, has a dual nature: pro-inflammatory at rest, it flips to anti-inflammatory during exercise, simultaneously reducing brain inflammation and downregulating tumor cell growth. The exercise-as-anti-cancer insight is delivered with real force: 30 minutes of daily aerobic activity can downregulate 13 types of cancer. Natural killer cells, mobilized by exercise, literally travel to tumor sites and destroy them. Meanwhile, Nicola points out that pharmaceutical companies are spending billions trying to synthetically replicate myokines in a drug — and cannot. The chapter closes with Nicola's explanation of neural real estate: the motor cortex dedicates more brain space to heavier lifts, meaning greater neural drive equals better brain development.

Similar podbits

Health & Fitness
AI in Healthcare: Where It Helps and Where It Doesn't

Using AI to Increase Your Intelligence & Enrich Humanity | … · Aug 10, 2026 Health & Fitness

AI nailed Andrew Huberman's vertigo-vs-low-blood-pressure diagnosis because that pattern has been reported millions of times. But every patient's liver is different and data on liver surgeries is scarce worldwide — making solo robot surgery dangerous. The rule is simple: data abundance means AI can help; data scarcity means keep the human in the loop.